Your browser doesn't support javascript.
loading
Nanoformulations - Insights Towards Characterization Techniques.
Krishnaswami, Venkateshwaran; Sugumaran, Abimanyu; Perumal, Venkatesan; Manavalan, Murugan; Kondeti, Durga Prasad; Basha, Shaik Kamil; Ahmed, Mohammed Akmal; Kumar, Munish; Vijayaraghavalu, Sivakumar.
Afiliação
  • Krishnaswami V; Department of Pharmaceutical Technology, University College of Engineering, Anna University, BIT Campus, Tiruchirappalli, Tamil Nadu, India.
  • Sugumaran A; Department of Pharmaceutics, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, India.
  • Perumal V; Center for Injury Biomechanics, Materials and Medicine, Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
  • Manavalan M; Department of Biomedical Engineering, Noorul Islam Center for Higher Education, Kumaracoil, Kanyakumari, Tamil Nadu, India.
  • Kondeti DP; Department of Pharmaceutical Chemistry, Narayana College of Pharmacy, Nellore 524003, Andhra Pradesh, India.
  • Basha SK; Department of Pharmaceutical Chemistry, Narayana College of Pharmacy, Nellore 524003, Andhra Pradesh, India.
  • Ahmed MA; Department of Pharmaceutical Chemistry, Narayana College of Pharmacy, Nellore 524003, Andhra Pradesh, India.
  • Kumar M; Department of Biochemistry, University of Allahabad, Prayagraj 211002, India.
  • Vijayaraghavalu S; Department of Life Sciences (Zoology), Manipur University, Imphal, Manipur, India.
Curr Drug Targets ; 23(14): 1330-1344, 2022.
Article em En | MEDLINE | ID: mdl-35996238

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Curr Drug Targets Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Curr Drug Targets Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia